.Turnstone Biologics is actually minimizing its headcount through 60% and shaking up its own C-suite...
.In a year that has found an authorization and a raft of readouts for metabolic dysfunction-associat...
.Alaunos Therapies is axing a deal with Precigen, quiting licensing liberties to a tailored T-cell p...
.Capricor Rehabs is taking a victory tour for their phase 2 Duchenne muscular dystrophy (DMD) trial....
.The FDA has positioned Kezar Life Sciences' lupus trial on grip after the biotech warned 4 deaths d...
.A stage 3 trial of Historian Stone's vertebral muscular degeneration (SMA) applicant has actually h...
.RNA biotech CAMP4 Rehabs has defined think about a $67 million IPO, with inflammation-focused Upstr...
.A year after the breakdown of an idiopathic lung fibrosis candidate delivered Galecto on a hunt for...
.Taking the mat is Judo Biography, an ambitious biotech armed with $100 thousand to develop oligonuc...
.AstraZeneca has actually paid CSPC Drug Group $one hundred thousand for a preclinical cardiovascula...